Skip to main navigation Skip to search Skip to main content

Liquid metal based theranostic nanoplatforms: Application in cancer therapy, imaging and biosensing

  • Sanjay Kulkarni
  • , Abhijeet Pandey
  • , Srinivas Mutalik*
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Liquid metals in recent years have grabbed the attention of researchers due to their expanded applicability not only in the field of therapeutics but also in theranostic. Acknowledged as a nuclear medicine due to its radioactivity, Gallium finds its widespread application in disorders of bone, calcium metabolism, and cancer. The present article deals with the advancement of gallium based nanoplatforms for therapy, imaging, and biosensing of cancers. The article describes the gallium based nanoconjugates and furnishes one's understanding of various therapeutic approaches such as photothermal therapy, sonodynamic therapy, radiotherapy, and immunotherapy along with various imaging platforms and biosensing platforms. A brief section related to patents on gallium based nanoplatforms in cancer has been included along with various molecular docking and simulation studies done on gallium. The recent advancement with respect to drug delivery gives an insight into the future perspective of gallium based nanoplatforms in the field of cancer theranostic.

Original languageEnglish
Article number102175
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume26
DOIs
Publication statusPublished - 06-2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • General Materials Science
  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Liquid metal based theranostic nanoplatforms: Application in cancer therapy, imaging and biosensing'. Together they form a unique fingerprint.

Cite this